Comparison 3. Artesunate plus sulfadoxine‐pyrimethamine (AS+SP) vs azithromycin plus sulfadoxine‐pyrimethamine (AZM+SP).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Treatment failure at delivery or day 40	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2 Treatment failure at delivery or day 40 (excludes new infections, detected by PCR)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
3 Maternal anaemia	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
4 Low birthweight	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
5 Perinatal death	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
6 Neonatal death	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected